tert-butyl 3-(acetylthio)azetidine-1-carboxylate

Catalog No.: 
ACXGWV140
CAS No.: 
183800-74-0
Molecular Formula: 
C10H17NO3S
Molecular Weight: 
231.09
tert-butyl 3-(acetylthio)azetidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$151.00InquiryInquiry
250mg97%$280.00InquiryInquiry
1g97%$590.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl 3-(acetylthio)azetidine-1-carboxylate
IUPAC Nametert-butyl 3-(acetylthio)azetidine-1-carboxylate
MDL No.MFCD24465865
Molecular FormulaC10H17NO3S
Molecular Weight231.09
SMILESO=C(N1CC(C1)SC(C)=O)OC(C)(C)C
InChI KeyNCTWTOSRADIIRF-UHFFFAOYSA-N
Synonymtert-Butyl 3-(acetylsulfanyl)azetidine-1-carboxylate;1-Azetidinecarboxylic acid, 3-(acetylthio)-, 1,1-dimethylethyl ester;tert-butyl 3-(acetylthio)azetidine-1-carboxylate - [AC80654]
CAS No.183800-74-0
PubChem CID18363257

Synthetic Route by SureRoute

1. ACXGWV140 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHCXZ590 route compound structure diagram
    ACHCXZ590254454-54-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXGWV140 route product structure diagram
    ACXGWV140183800-74-0
Inquiry

2. ACXGWV140 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHCXZ590 route compound structure diagram
    ACHCXZ590254454-54-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXGWV140 route product structure diagram
    ACXGWV140183800-74-0
Inquiry

3. ACXGWV140 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHCXZ590 route compound structure diagram
    ACHCXZ590254454-54-1In Stock
  4. Then
  5. ACXGWV140 route product structure diagram
    ACXGWV140183800-74-0
Inquiry

Comments (0)